Creative Net Income Applicable To Common Shares from 2010 to 2024

CELZ Stock  USD 2.67  0.02  0.75%   
Creative Medical Net Income Applicable To Common Shares yearly trend continues to be fairly stable with very little volatility. Net Income Applicable To Common Shares is likely to outpace its year average in 2024. Net Income Applicable To Common Shares is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Income Applicable To Common Shares  
First Reported
2016-12-31
Previous Quarter
-1.1 M
Current Value
-1.1 M
Quarterly Volatility
9.6 M
 
Covid
Check Creative Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Creative Medical's main balance sheet or income statement drivers, such as Selling General Administrative of 3.2 M, Other Operating Expenses of 5.9 M or Total Operating Expenses of 5.8 M, as well as many indicators such as Price To Sales Ratio of 757, Dividend Yield of 0.0039 or PTB Ratio of 0.66. Creative financial statements analysis is a perfect complement when working with Creative Medical Valuation or Volatility modules.
  
Check out the analysis of Creative Medical Correlation against competitors.

Latest Creative Medical's Net Income Applicable To Common Shares Growth Pattern

Below is the plot of the Net Income Applicable To Common Shares of Creative Medical Technology over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Creative Medical's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Creative Medical's overall financial position and show how it may be relating to other accounts over time.
Net Income Applicable To Common Shares10 Years Trend
Slightly volatile
   Net Income Applicable To Common Shares   
       Timeline  

Creative Net Income Applicable To Common Shares Regression Statistics

Arithmetic Mean787,246
Coefficient Of Variation1,842
Mean Deviation9,429,368
Median(28,012)
Standard Deviation14,499,003
Sample Variance210.2T
Range55.5M
R-Value0.29
Mean Square Error207T
R-Squared0.09
Significance0.29
Slope948,802
Total Sum of Squares2943.1T

Creative Net Income Applicable To Common Shares History

202418.2 M
202317.3 M
202119.2 M
2020-36.3 M
2019-8.5 M
2018-13.7 M
2017-2.7 M

About Creative Medical Financial Statements

Creative Medical investors use historical fundamental indicators, such as Creative Medical's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Creative Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Income Applicable To Common Shares17.3 M18.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Creative Stock Analysis

When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.